{
  "retracted": false,
  "timestamp": 1496707200000,
  "updates": [
    {
      "timestamp": 1581973861736,
      "identifier": {
        "doi": "10.1038/nm0617-788a"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1038/nm.4255"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction: Corrigendum: SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia"
}
